UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

Journal of clinical oncology, 2018-12, Vol.36 (34), p.3353-3360

2018

Volltextzugriff (PDF)

An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis

European urology, 2019-01, Vol.75 (1), p.201-203

2019

Volltextzugriff (PDF)

Erdafitinib for the treatment of urothelial cancer

Expert review of anticancer therapy, 2019-10, Vol.19 (10), p.835-846

2019

Volltextzugriff (PDF)

Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer

JNCI : Journal of the National Cancer Institute, 2021-01, Vol.113 (1), p.48-53

2021

Volltextzugriff (PDF)

Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment

The Journal of urology, 2013-11, Vol.190 (5), p.1919-1924

2013

Volltextzugriff (PDF)

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)

Clinical Medicine Insights. Oncology, 2021, Vol.15, p.11795549211021667-11795549211021667

2021

Volltextzugriff (PDF)

Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease

Urology (Ridgewood, N.J.), 2015-02, Vol.85 (2), p.402-406

2015

Volltextzugriff (PDF)

A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings

Clinical genitourinary cancer, 2016-08, Vol.14 (4), p.323-330

2016

Volltextzugriff (PDF)

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Clinical breast cancer, 2019-04, Vol.19 (2), p.e306-e318

2019

Volltextzugriff (PDF)

Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment

Clinical genitourinary cancer, 2021-06, Vol.19 (3), p.237-245.e2

2021

Volltextzugriff (PDF)

[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab

Urologic oncology, 2021-04, Vol.39 (4), p.235.e15-235.e21

2021

Volltextzugriff (PDF)

High-dose chemotherapy for germ cell tumors: do we have a model?

Expert opinion on biological therapy, 2015-01, Vol.15 (1), p.33-44

2015

Volltextzugriff (PDF)

Relationship between lymph node ratio and cancer‐specific survival in a contemporary series of patients with penile cancer and lymph node metastases

BJU international, 2015-11, Vol.116 (5), p.727-733

2015

Volltextzugriff (PDF)

Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group)

Immunotherapy, 2022-02, Vol.14 (2), p.107-114

2022

Volltextzugriff (PDF)

Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors

American journal of clinical oncology, 2017-02, Vol.40 (1), p.60-65

2017

Volltextzugriff (PDF)

Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma

Clinical genitourinary cancer, 2014-12, Vol.12 (6), p.433-439

2014

Volltextzugriff (PDF)

A Prognostic Model Including Pre- and Postsurgical Variables to Enhance Risk Stratification of Primary Mediastinal Nonseminomatous Germ Cell Tumors: The 27-Year Experience of a Referral Center

Clinical genitourinary cancer, 2015-02, Vol.13 (1), p.87-93.e1

2015

Volltextzugriff (PDF)

Combination of Paclitaxel, Cisplatin, and Gemcitabine (TPG) for Multiple Relapses or Platinum-Resistant Germ Cell Tumors: Long-Term Outcomes

Clinical genitourinary cancer, 2014-02, Vol.12 (1), p.63-69.e1

2014

Volltextzugriff (PDF)

Postchemotherapy Lymphadenectomy in Patients With Metastatic Urothelial Carcinoma: Long-Term Efficacy and Implications for Trial Design

Clinical genitourinary cancer, 2015-02, Vol.13 (1), p.80-86.e1

2015

Volltextzugriff (PDF)

Quality of Life and Pain Control following Laparoscopic Retroperitoneal Lymph Node Dissection in Early-stage Nonseminoma

Tumori, 2015-11, Vol.101 (6), p.650-656

2015

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(94)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(44)
Humans
(41)
Male
(23)
Oncology
(20)
Urology & Nephrology
(20)
Urology
(19)
Middle Aged
(18)
Adult
(15)
Aged
(14)
Treatment Outcome
(14)
Female
(11)
Prognosis
(11)
Retrospective Studies
(10)
Disease-Free Survival
(9)
Hematology, Oncology And Palliative Medicine
(9)
Urinary Bladder Neoplasms - Drug Therapy
(8)
Patients
(7)
Urinary Bladder Neoplasms - Pathology
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study

An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis

Erdafitinib for the treatment of urothelial cancer

Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer

Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)

Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease

A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment

[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab

High-dose chemotherapy for germ cell tumors: do we have a model?

Relationship between lymph node ratio and cancer‐specific survival in a contemporary series of patients with penile cancer and lymph node metastases

Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group)

Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study

Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy

Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors

Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma

A Prognostic Model Including Pre- and Postsurgical Variables to Enhance Risk Stratification of Primary Mediastinal Nonseminomatous Germ Cell Tumors: The 27-Year Experience of a Referral Center

Combination of Paclitaxel, Cisplatin, and Gemcitabine (TPG) for Multiple Relapses or Platinum-Resistant Germ Cell Tumors: Long-Term Outcomes

Postchemotherapy Lymphadenectomy in Patients With Metastatic Urothelial Carcinoma: Long-Term Efficacy and Implications for Trial Design

Quality of Life and Pain Control following Laparoscopic Retroperitoneal Lymph Node Dissection in Early-stage Nonseminoma

Suchergebnisse filtern